Yasser El Miedany1,2, Maha El Gaafary3,4, Sally Youssef3,4, Sami Bahlas3,4, Samah Almedany3,4, Ihab Ahmed3,4, Deborah Palmer3,4. 1. From King's College, London, UK; Rheumatology and Rehabilitation, and Community and Public Health, Ain Shams University, Cairo, Egypt; Rheumatology Department, King Abdel Aziz University, Jeddah, Saudi Arabia; Rheumatology and Rehabilitation, Tanta University, Tanta; Internal Medicine, Cairo University, Egypt; Rheumatology, North Middlesex University Hospitals, London, UK. drelmiedany@rheumatology4u.com. 2. Y. El Miedany, MD, FRCP, Honorary senior clinical lecturer, King's College; M. El Gaafary, MD, Community and Public Health, Ain Shams University; S. Youssef, MD, Rheumatology and Rehabilitation, Ain Shams University; S. Bahlas, MD, Rheumatology Department, King Abdel Aziz University; S. Almedany, MD, Rheumatology and Rehabilitation, Tanta University; I. Ahmed, MRCP, Internal Medicine, Cairo University; D. Palmer, Dip Rheum Nursing, Rheumatology, North Middlesex University Hospitals. drelmiedany@rheumatology4u.com. 3. From King's College, London, UK; Rheumatology and Rehabilitation, and Community and Public Health, Ain Shams University, Cairo, Egypt; Rheumatology Department, King Abdel Aziz University, Jeddah, Saudi Arabia; Rheumatology and Rehabilitation, Tanta University, Tanta; Internal Medicine, Cairo University, Egypt; Rheumatology, North Middlesex University Hospitals, London, UK. 4. Y. El Miedany, MD, FRCP, Honorary senior clinical lecturer, King's College; M. El Gaafary, MD, Community and Public Health, Ain Shams University; S. Youssef, MD, Rheumatology and Rehabilitation, Ain Shams University; S. Bahlas, MD, Rheumatology Department, King Abdel Aziz University; S. Almedany, MD, Rheumatology and Rehabilitation, Tanta University; I. Ahmed, MRCP, Internal Medicine, Cairo University; D. Palmer, Dip Rheum Nursing, Rheumatology, North Middlesex University Hospitals.
Abstract
OBJECTIVE: To assess the use of electronic patient-reported outcome measures (ePROM) in standard clinical practice for early rheumatoid arthritis (RA) management, the ePROM ability to enhance clinical care, and how computing technology can improve the patients' adherence to therapy. METHODS: In a double-blinded randomized-controlled study, 211 patients with early RA diagnosed according to American College of Rheumatology/European League Against Rheumatism criteria completed a PROM in paper format at their first clinic visit. Patients were then randomized to Group 1, which completed an ePROM questionnaire monthly, or Group 2, which continued the standard paper PROM format. Over a 12-month period, Group 1 patients were assessed every 3 months in the clinic, whereas Group 2 patients were assessed in the clinic initially monthly for 6 months, then every 3 months. The primary endpoint was the equivalence of outcomes [Routine Assessment of Patient Index Data 3 (RAPID-3) and 28-joint Disease Activity Score (DAS28)] in both groups. The secondary endpoint was the patients' adherence to their medications. RESULTS: There was no significant difference between disease activity measures as well as DAS28 and RAPID-3 scores at 3, 6, and 12 months of management, although there was a trend toward lower patient-reported tender joint count and functional disability score in the active group versus the control group. The patients' adherence to antirheumatic therapy was significantly higher (p < 0.01) in the ePROM group, whereas stopping disease-modifying antirheumatic drugs for intolerability was significantly higher (p < 0.01) in the control group at 12 months of treatment. CONCLUSION: We found ePROM equivalent to standard paper PROM format. Further, it enabled the patients to personally monitor how they are doing regarding their disease activity and helped to optimize their adherence to their treatment.
RCT Entities:
OBJECTIVE: To assess the use of electronic patient-reported outcome measures (ePROM) in standard clinical practice for early rheumatoid arthritis (RA) management, the ePROM ability to enhance clinical care, and how computing technology can improve the patients' adherence to therapy. METHODS: In a double-blinded randomized-controlled study, 211 patients with early RA diagnosed according to American College of Rheumatology/European League Against Rheumatism criteria completed a PROM in paper format at their first clinic visit. Patients were then randomized to Group 1, which completed an ePROM questionnaire monthly, or Group 2, which continued the standard paper PROM format. Over a 12-month period, Group 1 patients were assessed every 3 months in the clinic, whereas Group 2 patients were assessed in the clinic initially monthly for 6 months, then every 3 months. The primary endpoint was the equivalence of outcomes [Routine Assessment of Patient Index Data 3 (RAPID-3) and 28-joint Disease Activity Score (DAS28)] in both groups. The secondary endpoint was the patients' adherence to their medications. RESULTS: There was no significant difference between disease activity measures as well as DAS28 and RAPID-3 scores at 3, 6, and 12 months of management, although there was a trend toward lower patient-reported tender joint count and functional disability score in the active group versus the control group. The patients' adherence to antirheumatic therapy was significantly higher (p < 0.01) in the ePROM group, whereas stopping disease-modifying antirheumatic drugs for intolerability was significantly higher (p < 0.01) in the control group at 12 months of treatment. CONCLUSION: We found ePROM equivalent to standard paper PROM format. Further, it enabled the patients to personally monitor how they are doing regarding their disease activity and helped to optimize their adherence to their treatment.
Entities:
Keywords:
ADHERENCE; EARLY ARTHRITIS; ELECTRONIC MEDICAL RECORDS; PATIENT-REPORTED OUTCOME MEASURES
Authors: Y El Miedany; M El Gaafary; Nadia El Aroussy; S Bahlas; M Hegazi; D Palmer; S Youssef Journal: Clin Rheumatol Date: 2017-05-31 Impact factor: 2.980
Authors: Emanuele M Giusti; Giada Pietrabissa; Gian Mauro Manzoni; Roberto Cattivelli; Enrico Molinari; Hester R Trompetter; Karlein M G Schreurs; Gianluca Castelnuovo Journal: Front Psychol Date: 2017-10-31
Authors: Bruno Fautrel; Rieke Alten; Bruce Kirkham; Inmaculada de la Torre; Frederick Durand; Jane Barry; Thorsten Holzkaemper; Walid Fakhouri; Peter C Taylor Journal: Rheumatol Int Date: 2018-03-21 Impact factor: 2.631
Authors: Marion Magnol; Berard Eleonore; Rempenault Claire; Benjamin Castagne; Marine Pugibet; Cédric Lukas; Anne Tournadre; Pascale Vergne-Salle; Thomas Barnetche; Marie-Elise Truchetet; Adeline Ruyssen-Witrand Journal: J Med Internet Res Date: 2021-01-29 Impact factor: 5.428
Authors: Dmytro Fedkov; Andrea Berghofen; Christel Weiss; Christine Peine; Felix Lang; Johannes Knitza; Sebastian Kuhn; Bernhard K Krämer; Jan Leipe Journal: Rheumatol Int Date: 2022-09-16 Impact factor: 3.580